|
[Lys(Ac)4]-Histone H3 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Arg(Me1)3]-Histone H4 (1-23)-GGK(Biotin) - 1 mg
|
|
|
|
[Cys26]-beta-Amyloid (1-42)
|
|
|
|
(2R, 3S)/(2S, 3R)-Racemic Fmoc-beta-hydroxyphenylalanine - 5 g
|
|
487060-72-0
|
|
[Arg(Me1)17]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Ac)12/16, Lys(Me3)20]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
[Gla17,21,24]-Osteocalcin (1-49)
|
|
136461-80-8
|
|
[Lys(Ac)56]-Histone H3 (44-63) - 1 mg
|
|
|
|
[Asn23]-beta-Amyloid (1-40), Iowa Mutation - 0.5 mg
|
|
374796-72-2
|
|
[Leu31, Pro34]-Neuropeptide Y, human, rat - 1 mg
|
|
132699-73-1
|
|
[Leu5]-Enkephalin - 25 mg
|
|
58822-25-6
|
|
[Arg(Me2a)8]-Histone H3(1-21)-K(Biotin)-NH2 - 1 mg
|
|
|
|
[Glu1]-Fibrinopeptide B - 1 mg
|
|
103213-49-6
|
|
[Lys(Ac)9]-Histone H3 (1-20) - 1 mg
|
|
|
|
[Arg6]-beta-Amyloid (1-40), England Mutation - 0.5 mg
|
|
1802084-26-9
|
|
[Lys(Ac)36]-Histone H3 (21-44)-GK(Biotin) - 1 mg
|
|
|
|
[Glu3]-RGES, Control for RGD Peptides - 1 mg
|
|
93674-97-6
|
|
[Ala13]-Apelin-13 - 1 mg
|
|
568565-11-7
|
|
[Lys(Ac)8]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
(Biotin-LC) - SARS-CoV-2 Spike receptor binding motif, RBM (438-458) - 0.1 mg
|
|
|
|
[Arg(Me1)8]-Histone H3 (1-21)-K(Biotin)-NH2 - 1 mg
|
|
|
|
(R)-N-Fmoc-2-(7'-octenyl) alanine - 1 g
|
|
945212-26-0
|
|
[Gln22]-beta-Amyloid (1-40), Dutch Mutation - 0.5 mg
|
|
144410-00-4
|
|
[Lys(Ac)9]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
[Gly21]-beta-Amyloid (1-40), A21G, Flemish Mutation - 0.5 mg
|
|
154362-03-5
|
|
(Arg)9 - 1 mg
|
|
143413-47-2
|
|
[Arg(Me2a)3]-Histone H4 (1-23)-GGK(Biotin) - 1 mg
|
|
|
|
(Arg)9, TAMRA-labeled - 1 mg
|
|
|
|
[Arg(Me2s)8]-Histone H3 (1-21)-K(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)27]-Histone H3 (23-34) - 1 mg
|
|
|
|
[Lys(Me1)20]-Histone H4 (8-30)-WGK(Biotin) - 1 mg
|
|
|
|
(S)-N-Fmoc-2-(4'-pentenyl)glycine
|
|
856412-22-1
|
|
[Arg8]-Vasopressin (AVP) Peptide
|
|
113-79-1
|
|
[Gln22]-beta-Amyloid (1-42), Dutch mutation - 0.5 mg
|
|
|
|
[Lys(Ac)14/18/23/27]-Histone H3 (1-30)-GGK(Biotin) - 1 mg
|
|
|
|
(S)-N-Fmoc-2-(7'-octenyl) alanine 1 g
|
|
288617-75-4
|
|
[Cit 2/8/17]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 0.25 mg
|
|
|
|
[Lys(Me1)18]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Ac)16]-Histone H4 (1-20) - 1 mg
|
|
|
|
[Des-octanoyl]-Ghrelin, rat, mouse - 1 mg
|
|
307950-60-3
|
|
[Lys(Ac)5]-Histone H4 (1-20) - 1 mg
|
|
|
|
[Lys(Ac)14]-Histone H3 (9-19) - 1 mg
|
|
|
|
[Lys(Ac)5/8/12/16] - Histone H4 (1-25) - GSGSK - 1 mg
|
|
|
|
[Gln22,Asn23]-beta-Amyloid (1-40), Dutch/Iowa double mutation - 0.5 mg
|
|
374796-75-5
|
|
[Lys(Ac)14]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
[Cit17]-Histone H3 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Gly22]-beta-Amyloid (1-40), Arctic Mutation - 0.5 mg
|
|
175010-18-1
|
|
(Arg)9 biotin labeled - 1 mg
|
|
|
|
[Arg6]-beta-Amyloid (1-42), English Mutation - 0.5 mg
|
|
|
|
[Lys(Ac)23]-Histone H3 (21-44)-GK(Biotin) - 1 mg
|
|
|
|
(S)-N-Fmoc-2-(4'-pentenyl) alanine
|
|
288617-73-2
|
|
[Lys(Ac)12]-Histone H4 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Me1)23]-Histone H3 (21-44)-GK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Me1)12]-Histone H4(1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)8]-Histone H4 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)5/8/12/16]-Histone H4 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)5]-Histone H4 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Arg(Me2a)26]-Histone H3 (15-36)-GGK(Biotin) - 1 mg
|
|
|
|
[Gly22]-beta-Amyloid (1-42), Arctic Mutation - 0.5 mg
|
|
1802086-23-2
|
|
[Cys(HiLyte Fluor 647 C2 maleimide)]-Exendin-4 - 50 μg
|
|
|
|
[Arg(Me2s)26]-Histone H3 (15-36)-GGK(Biotin) - 1 mg
|
|
|
|
[Cit26]-Histone H3 (21-44)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)9/14]-Histone H3 (1-21)-GGK(Biotin)
|
|
|
|
[Lys(Ac)9]-Histone H3 (1-24) - 1 mg
|
|
|
|
[Lys(Ac)382]-p53 (361-393), human, biotin-labeled, amide - 1 mg
|
|
|
|
[Arg(Me2s)3]-Histone H4 (1-23)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)20]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
[Arg(Me2s)3]-Histone H4 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)18]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Asn23]-beta-amyloid (1-42), Iowa Mutation - 0.5 mg
|
|
|
|
[Lys(Ac)27]-Histone 3 (21-44)-GK(Biotin)-NH2 - 1 mg
|
|
|
|
[Arg(Me1)3]-Histone H4(1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Cit3]-Histone H4 (1-23)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)9]-Histone H3 (1-21) - 1 mg
|
|
|
|
[Lys(Ac) 5/8/12/16]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)382]-p53 (372-389), human - 1 mg
|
|
|
|
[Des-Arg10]-HOE I40, B1 Bradykinin Receptor Antagonist - 1 mg
|
|
|
|
[Lys(Ac)14]-Histone H3 (1-19) - 1 mg
|
|
|
|
[Lys(Ac)14/18/23]-Histone H3 (1-24)-GGK(Biotin) - 1 mg
|
|
|
|
[Lys(Me1)20]-Histone H4 (1-23)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Gly21]-beta-Amyloid (1-42), Dutch Mutation - 0.5 mg
|
|
|
|
[Des-octanoyl]-Ghrelin, human - 1 mg
|
|
313951-59-6
|
|
[Lys(Ac)16]-Histone H4 (1-21)-GGK(Biotin) - 1 mg
|
|
|
|
(2S)-N-Fmoc-5-azido-pentanoic acid
|
|
1097192-04-5
|
|
[Asn7]-beta-Amyloid (1-42), Tottori-Japanese Mutation - 0.5 mg
|
|
|
|
[Lys(Ac)382]-p53 (372-389), human, biotin labeled - 1 mg
|
|
|
|
[Lys(Ac)12/16]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
(Arg)9, FAM-labeled - 1 mg
|
|
|
|
[Lys(Ac)12]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
[Leu27]-Melan-A, MART-1 (26-35) - 1 mg
|
|
|
|
[Lys(Ac)79]-Histone H3 (69-89)-K(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)5]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
[Lys(Ac)8]-Histone H4 (1-20) - 1 mg
|
|
|
|
[D-Tyr6, -Ala11, Phe13, Nle14]-Bombesin (6-14) - 1 mg
|
|
|
|
[Lys(Ac)12]-Histone H4 (1-20) - 1 mg
|
|
|
|
[Lys(Ac)16]-Histone H4 (1-25)-GSGSK(Biotin) - 1 mg
|
|
|
|
[Arg(Me2a)3]-Histone H4(1-21)-GGK(Biotin) - 1 mg
|
|
|
|
[Asn7]-beta-Amyloid (1-40), Tottori-Japan Mutation - 0.5 mg
|
|
1802086-32-3
|
|
[Lys(Ac)9] - Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
|
|
|
|
[Lys(Ac)27]-Histone H3 (21-43)-GGK(Biotin) - 1 mg
|
|
|